The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

Insulin resistance and hepatic lipid accumulation constitute the metabolic underpinning of nonalcoholic steatohepatitis (NASH). We tested the hypothesis that saroglitazar, a PPAR α/γ agonist would improve NASH in the diet-induced animal model of NAFLD. Mice received chow diet and normal water (CDNW)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Divya P., Caffrey, Rebecca, Marioneaux, Jonathon, Santhekadur, Prasanna K., Bhat, Madhavi, Alonso, Cristina, Koduru, Srinivas V., Philip, Binu, Jain, Mukul R., Giri, Suresh R., Bedossa, Pierre, Sanyal, Arun J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283326/
https://www.ncbi.nlm.nih.gov/pubmed/32518275
http://dx.doi.org/10.1038/s41598-020-66458-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283326/
https://www.ncbi.nlm.nih.gov/pubmed/32518275
http://dx.doi.org/10.1038/s41598-020-66458-z

Ejemplares similares